Osaic Holdings Inc. Sells 36,416 Shares of SPDR S&P Biotech ETF $XBI

Osaic Holdings Inc. lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.4% in the 2nd quarter, Holdings Channel.com reports. The fund owned 72,482 shares of the exchange traded fund’s stock after selling 36,416 shares during the period. Osaic Holdings Inc.’s holdings in SPDR S&P Biotech ETF were worth $6,006,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. DHJJ Financial Advisors Ltd. bought a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $25,000. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth $32,000. Johnson Financial Group Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth $31,000. AlphaCore Capital LLC boosted its stake in SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after buying an additional 532 shares during the period. Finally, Quaker Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 101.2% during the second quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 53,536 shares during the period.

SPDR S&P Biotech ETF Stock Up 2.0%

Shares of NYSEARCA XBI opened at $125.91 on Tuesday. The stock’s 50-day simple moving average is $115.61 and its two-hundred day simple moving average is $99.12. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $126.50. The firm has a market capitalization of $7.64 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.